Wire Stories
-
29.2K2023 Harbin Ice & Snow Expo Was Successfully Held on March 17-19
HARBIN, China–(BUSINESS WIRE)–#Harbin–The 2023 Harbin Ice & Snow Expo, themed on “seeking development in the new paradigm and promoting the revitalization with...
-
24.0KJuniper Research: Fraudulent Robocalls to Cost Mobile Subscribers a Record $58 Billion Globally this Year, Finds Juniper Research Study
BASINGSTOKE, England–(BUSINESS WIRE)–A new report from Juniper Research, foremost experts assessing emerging communications technologies, has found that mobile subscribers will lose $58...
-
27.8KDNP Develops TGV Glass Core Substrate for Semiconductor Packages
– Contributing to higher performance semiconductors – TOKYO–(BUSINESS WIRE)–Dai Nippon Printing Co., Ltd. (DNP, TOKYO: 7912) has developed a Glass Core Substrate...
-
26.1KGuardforce Security Adopts Hytera Push-to-talk to Improve Operational Efficiency
BANGKOK–(BUSINESS WIRE)–#CommunicationSolutions–Hytera Communications (SZSE: 002583), a leading global provider of professional communications technologies and solutions, has been providing Guardforce Security Thailand with...
-
25.7KPatritumab Deruxtecan Continues to Show Encouraging Clinical Activity in Distinct Patient Populations with Metastatic Lung and Breast Cancer in Updated Results of Two Early Trials
Updated results from phase 1 trial, including first presentation of data from a cohort of patients with EGFR-mutated metastatic non-small cell lung...
-
25.6KAttentive Launches in APAC Region as Global Expansion Continues
SMS-first platform leader opens in Australia to empower brands to create personalised experiences and drive revenue SYDNEY–(BUSINESS WIRE)–Attentive, the conversational commerce platform,...
-
25.3KRio Tinto publishes independent report on cultural heritage management performance
MELBOURNE, Australia–(BUSINESS WIRE)–Rio Tinto today published an independent report based on a global audit of its Cultural Heritage Management compliance and performance...
-
28.3KConnect Biopharma CBP-201 Atopic Dermatitis China Pivotal Study Showed Rapid Relief of Patient Symptoms
Late-Breaking Abstract and Oral Presentation at American Academy of Dermatology Annual Meeting Stage 1 of ongoing 52-week China pivotal AD trial met...
-
32.7KHKSTP’s Global Talent Mission Hits Top Gear with �Gamified Career Journey in Live� Event and Hong Kong�s Largest I&T Career Expo Kick-Off
I&T Career Expo 2023 offers 2,500+ jobs from over 250 companies to attract global talent HONG KONG–(BUSINESS WIRE)–Hong Kong Science and Technology...
-
24.3KTakeda Announces Positive Results in Phase 2b Study of Investigational TAK-279, an Oral, Once-Daily TYK2 Inhibitor, in People with Moderate-to-Severe Plaque Psoriasis
Results for TAK-279 (Formerly NDI-034858) Show a Significantly Greater Proportion of Patients Achieved Psoriasis Area and Severity Index (PASI) 75 at Doses...
To Top